glp-1 agonist common side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Exploring the Side Effects of

Aim for 0.7-1 gram of protein per pound of ideal body weight daily

The largest meta-analysis to date, comprising 13 cardiovascular outcome trials involving 83,258 patients with and without diabetes, confirmed that GLP-1 Ras significantly reduced major adverse cardiovascular events (MACEs), all-cause mortality, cardiovascular mortality, fatal and non-fatal strokes, coronary revascularization, and composite kidney outcomes [87]

& Lavecchia, A

Clinical trial data from the STEP 1 and SURMOUNT-1 trials show that patients typically achieve 1015% total body weight loss with semaglutide 2.4 mg weekly (Wegovy) and 1520% with tirzepatide 1015 mg weekly (Zepbound) over 1218 months

Blood-Brain Glucose Transfer in Alzheimers Disease: Effect of GLP-1 Analog Treatment. Scientific Reports, vol